Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuji Shibata

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid)Akira Sugimoto, Shingo Matsumoto, Hibiki Udagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2024
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-AsiaYuki Kato, Hibiki Udagawa, Shingo Matsumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2025
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)Yuji Uehara, Hiroki Izumi, Ikei S Kobayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 26, 2024
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-AsiaMasanobu Okahisa, Hibiki Udagawa, Shingo Matsumoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of GedatolisibShigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 18, 2026
Loss of payload sensitivity and other mechanisms of resistance to T-DXd in HER2-mutant NSCLC: implications for subsequent responsiveness to HER2 TKIsMonique B Nilsson, Xiuning Le, Alissa Poteete, et al.
Nature|November 25, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerHiroki Izumi, Shingo Matsumoto, Jie Liu, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2022
A Large-Scale Prospective Concordance Study of Plasma- and Tissue-Based Next-Generation Targeted Sequencing for Advanced Non-Small Cell Lung Cancer (LC-SCRUM-Liquid)Akira Sugimoto, Shingo Matsumoto, Hibiki Udagawa, et al.
Lung Cancer (Amsterdam, Netherlands)|October 18, 2024
Efficacy of immune checkpoint inhibitors plus platinum-based chemotherapy as 1st line treatment for patients with non-small cell lung cancer harboring HER2 mutations: Results from LC-SCRUM-AsiaYuki Kato, Hibiki Udagawa, Shingo Matsumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|March 15, 2025
Efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer with EGFR exon 19 insertions: clinical-genomic, preclinical analysis through LC-SCRUM-Asia (multi-institutional genomic screening registry)Yuji Uehara, Hiroki Izumi, Ikei S Kobayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 26, 2024
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-AsiaMasanobu Okahisa, Hibiki Udagawa, Shingo Matsumoto, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 12, 2024
Clinical Significance of a Prospective Large Genomic Screening for SCLC: The Genetic Classification and a Biomarker-Driven Phase 2 Trial of GedatolisibShigeki Umemura, Hibiki Udagawa, Takaya Ikeda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 18, 2026
Loss of payload sensitivity and other mechanisms of resistance to T-DXd in HER2-mutant NSCLC: implications for subsequent responsiveness to HER2 TKIsMonique B Nilsson, Xiuning Le, Alissa Poteete, et al.
Nature|November 25, 2021
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancerHiroki Izumi, Shingo Matsumoto, Jie Liu, et al.
Pageof 6